Showing 2,601 - 2,620 results of 12,750 for search '"therapeutics"', query time: 0.07s Refine Results
  1. 2601

    CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance by Kayode Komolafe, Maricica Pacurari

    Published 2022-01-01
    “…The potential therapeutic benefits of pharmacological or other CXCL/CXCR axis manipulations are also discussed.…”
    Get full text
    Article
  2. 2602
  3. 2603

    Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein by Marie-Lynn Cuypers, Tom Jaspers, Jarne Clerckx, Simon Leekens, Christopher Cawthorne, Guy Bormans, Frederik Cleeren, Nick Geukens, Bart De Strooper, Maarten Dewilde

    Published 2025-01-01
    “…The most well-studied approach to enhance brain influx of protein therapeutics, is receptor-mediated transcytosis (RMT) by targeting nutrient receptors to shuttle protein therapeutics over the blood–brain barrier (BBB) along with their endogenous cargos. …”
    Get full text
    Article
  4. 2604

    Bacterial metabolism in the host and its association with virulence by Amrita Bhagwat, Tiyasa Haldar, Poonam Kanojiya, Sunil D. Saroj

    Published 2025-12-01
    “…The knowledge of crosslinked metabolic pathways of bacteria and their host will serve to develop novel potential therapeutics.…”
    Get full text
    Article
  5. 2605

    Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD/SCA3 model. by Mimi Cushman-Nick, Nancy M Bonini, James Shorter

    Published 2013-01-01
    “…There are no effective therapeutics that antagonize or reverse the protein-misfolding events underpinning polyglutamine (PolyQ) disorders, including Spinocerebellar Ataxia Type-3 (SCA3). …”
    Get full text
    Article
  6. 2606

    Artificial intelligence (AI) or augmented intelligence? How big data and AI are transforming healthcare: Challenges and opportunities by K Moodley

    Published 2023-12-01
    “…A transformed healthcare environment enhanced by innovation, robotics, digital technology, and improved diagnostics and therapeutics is plagued by ethical, legal and social challenges. …”
    Get full text
    Article
  7. 2607
  8. 2608

    Molecular and cellular characteristics of cerebrovascular cell types and their contribution to neurodegenerative diseases by Francisco J. Garcia, Myriam Heiman

    Published 2025-01-01
    “…Abstract Many diseases and disorders of the nervous system suffer from a lack of adequate therapeutics to halt or slow disease progression, and to this day, no cure exists for any of the fatal neurodegenerative diseases. …”
    Get full text
    Article
  9. 2609

    ABO Blood Groups and Cardiovascular Diseases by Hanrui Zhang, Ciarán J. Mooney, Muredach P. Reilly

    Published 2012-01-01
    “…The role of blood group antigens in the pathogenesis of various cardiovascular disorders remains a fascinating subject with potential to lead to novel therapeutics and prognostics and to reduce the global burden of cardiovascular diseases.…”
    Get full text
    Article
  10. 2610

    Physiological Roles of DNA Double-Strand Breaks by Farhaan A. Khan, Syed O. Ali

    Published 2017-01-01
    “…Growing evidence points to a role of aberrant DSB physiology in human disease and an understanding of these processes may both inform the design of new therapeutic strategies and reduce off-target effects of existing drugs. …”
    Get full text
    Article
  11. 2611
  12. 2612

    A pan-orthohantavirus human lung xenograft mouse model and its utility for preclinical studies. by Melanie Rissmann, Danny Noack, Thomas M Spliethof, Vincent P Vaes, Rianne Stam, Peter van Run, Jordan J Clark, Georges M G M Verjans, Bart L Haagmans, Florian Krammer, Marion P G Koopmans, Judith M A van den Brand, Barry Rockx

    Published 2025-01-01
    “…Here, we describe the use of a human lung xenograft mouse model to study the permissiveness for different orthohantavirus species and to assess its utility for preclinical testing of therapeutics. Following infection of xenografted human lung tissues, distinct orthohantavirus species differentially replicated in the human lung and subsequently spread systemically. …”
    Get full text
    Article
  13. 2613

    Neuromuscular diseases: genomics-driven advances by Anna Cho

    Published 2024-11-01
    “…Continued progress in gene therapy, RNA-based therapeutics, and personalized medicine holds promise for further breakthroughs in the management of these debilitating diseases.…”
    Get full text
    Article
  14. 2614

    Comprehensive genome-scale CRISPR knockout screening of CHO cells by Sung Wook Shin, Su Hyun Kim, Aghiles Gasselin, Gyun Min Lee, Jae Seong Lee

    Published 2025-01-01
    “…Abstract Chinese hamster ovary (CHO) cells play a pivotal role in the production of recombinant therapeutics. In the present study, we conducted a genome-scale pooled CRISPR knockout (KO) screening using a virus-free, recombinase-mediated cassette exchange-based platform in CHO-K1 host and CHO-K1 derived recombinant cells. …”
    Get full text
    Article
  15. 2615
  16. 2616

    Molecular glue degrader for tumor treatment by Yuhan Hu, Yan Yan, Jiehao Wang, Jiangxue Hou, Quande Lin

    Published 2024-12-01
    “…Given that molecular glue research is still in its early stage, we summarized the mechanisms of molecular glue, the promising drugs in clinical trials and diverse feasible design strategies for molecular glue therapeutics.…”
    Get full text
    Article
  17. 2617

    Nanocurcumin in myocardial infarction therapy: emerging trends and future directions by Mei Lv, Qing Sun, Yilin Yu, Jinwei Bao

    Published 2025-01-01
    “…Research and clinical trials are essential for comprehensive analysis and efficacy of curcumin-based nano-therapeutics in cardiovascular condition and lowering risk of MI.…”
    Get full text
    Article
  18. 2618
  19. 2619
  20. 2620

    Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies by Aarat Patel, Georgia Seely, Rohit Aggarwal

    Published 2016-01-01
    “…There are few approved therapeutics available for treatment of this group of diseases and the first-line therapy is usually corticosteroid treatment. …”
    Get full text
    Article